Sirpa A. Hartikainen

Identifying drugs associated with Alzheimer's disease risk using machine learning-assisted signal detection

Background Several Alzheimer's disease (AD) clinical trials currently focus on drug repurposing. Machine learning (ML)-based pharmacoepidemiological approaches may help identify candidate drugs for trials. Objective We applied an ML-based signal detection method to identify drugs...